Verena Karsten is an accomplished clinical scientist currently serving as Executive Director at Eli Lilly and Company since October 2025, following the acquisition of Verve Therapeutics, where responsibilities were carried over. Prior experience includes leadership roles at Verve Therapeutics, advancing from Executive Director to Senior Director of Clinical Research from August 2022 to October 2025. Verena has also held the position of Director of Clinical Research at CRISPR Therapeutics (March 2020 - June 2022) and various positions at Alnylam Pharmaceuticals, including Associate Director and Senior Clinical Scientist from 2010 to February 2020. Earlier career phases feature roles at Vion Pharmaceuticals and a postdoctoral fellowship at Yale University. Verena holds a PhD in Infectious Diseases from Freie Universität Berlin.
This person is not in the org chart
This person is not in any teams
This person is not in any offices